Compare CING & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CING | HYPR |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | 13 | 111 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.1M | 109.7M |
| IPO Year | N/A | 2021 |
| Metric | CING | HYPR |
|---|---|---|
| Price | $6.28 | $1.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $36.00 | $1.45 |
| AVG Volume (30 Days) | ★ 629.7K | 500.8K |
| Earning Date | 03-18-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,563,000.00 |
| Revenue This Year | N/A | $35.37 |
| Revenue Next Year | $556.59 | $18.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.22 |
| 52 Week Low | $3.20 | $0.53 |
| 52 Week High | $11.89 | $2.22 |
| Indicator | CING | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 44.10 | 43.50 |
| Support Level | $3.77 | $1.04 |
| Resistance Level | $6.41 | $1.17 |
| Average True Range (ATR) | 1.11 | 0.09 |
| MACD | -0.34 | -0.01 |
| Stochastic Oscillator | 5.93 | 4.84 |
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.